Problem statement: Answer the multiple-choice question.
Query: Which compound exhibits a 19.147% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a.) O=[N+]([O-])c1ccc(S(=O)(=O)NCCCc2ccccc2)cc1
b.) CCC(C)[C@H](NC(=O)NCC1CCCO1)C(=O)OC
c.) COc1ccc(Cc2nnc(Nc3ccc(Cl)cc3)[nH]c2=O)cc1
Answer: b. CCC(C)[C@H](NC(=O)NCC1CCCO1)C(=O)OC
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCC(C)[C@H](NC(=O)NCC1CCCO1)C(=O)OC
CCC(C)[C@H](NC(=O)NCC1CCCO1)C(=O)OC
methyl (2S)-3-methyl-2-(oxolan-2-ylmethylcarbamoylamino)pentanoate